0.8335
Schlusskurs vom Vortag:
$0.88
Offen:
$0.88
24-Stunden-Volumen:
35,016
Relative Volume:
0.06
Marktkapitalisierung:
$7.35M
Einnahmen:
$453.30K
Nettoeinkommen (Verlust:
$-1.03M
KGV:
-7.3631
EPS:
-0.1132
Netto-Cashflow:
-
1W Leistung:
-0.77%
1M Leistung:
-11.62%
6M Leistung:
-30.54%
1J Leistung:
-50.97%
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Firmenname
X T L Biopharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XTLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
0.8335 | 7.76M | 453.30K | -1.03M | 0 | -0.1132 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-05-08 | Eingeleitet | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten
XTL Biopharmaceuticals Announces CFO Transition Amid Strategic Appointments - TipRanks
Total debt per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A2DK34 - TradingView
Changes in working capital of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:H2K2 - TradingView
XTL Biopharmaceuticals Announces Board Changes Following Resignation - MSN
Nothing is Better Than Stitch Fix Inc (SFIX) stock at the moment - Setenews
XTL Biopharmaceuticals Approves Key Resolutions at Shareholder Meeting - TipRanks
XTL Biopharmaceuticals Postpones Shareholders’ Meeting Due to Quorum Issue - TipRanks
XTL Biopharmaceuticals Announces Shareholder Meeting for Key Decisions - TipRanks
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Reports Financial Results Amid Regional Unrest - TipRanks
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Confirms Board and Auditor Appointments - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - Investing.com India
XTLB Stock Price and Chart — NASDAQ:XTLB - TradingView
XTL Biopharmaceuticals Ltd Share Price ADR Each Repr 100 Shs Spon - Hargreaves Lansdown
XTLB Financial Statements & ChartsX.t.l. Biopharmaceuticals Ltd.Adr MacroTrends - CMLviz
XTLB Pivot Points, Technical Analysis and Moving AveragesX.t.l. Biopharmaceuticals Ltd.Adr Technicals - CMLviz
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance
List of US Companies Releasing Earnings (EPS) Today - FXLeaders
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga
XTLB Stock Price and Chart — TASE:XTLB - TradingView
XTLB Stock Price | XTL Biopharmaceuticals Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
XTLBX.T.L. Biopharmaceuticals Ltd. ADR Stock Price and Quote - Finviz
INGN Stock Price | Inogen Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):